Pathology and epidemiology of HPV infection in females

Gynecologic Oncology

Volumn 117, Issue 2 SUPPL., 2010, Pages S5-

  Stanley, Margaret ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cervical intraepithelial neoplasm CIN; Cervix cancer; HPV infection cycle; HPV natural history

Indexed keywords

PROTEIN E6; PROTEIN E7; VIRUS DNA;

ANUS CANCER; CANCER GRADING; CANCER INVASION; CANCER RISK; CANCER SCREENING; CELL DIFFERENTIATION; CELL DIVISION; CONDYLOMA ACUMINATUM; CYTOLOGY; DEVELOPED COUNTRY; DISEASE COURSE; FEMALE GENITAL TRACT CANCER; GENE EXPRESSION; HEAD AND NECK CANCER; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; INFECTION RISK; NONHUMAN; PATHOPHYSIOLOGY; PENIS CANCER; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEXUAL TRANSMISSION; SQUAMOUS CELL METAPLASIA; SQUAMOUS EPITHELIUM; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VAGINA CANCER; VERRUCA VULGARIS; VULVA CANCER;

EID: 77949433498     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.01.024     Document Type: Review

References (42)

1. Meisels A., and Fortin R. Condylomatous lesions of the cervix and vagina. I. Cytologic patterns. Acta Cytol. 20 (1976) 505-509
2. Meisels A., Fortin R., and Roy M. Condylomatous lesions of the cervix. II. Cytologic, colposcopic and histopathologic study. Acta Cytol. 21 (1977) 379-390
3. Gissmann L., and zur Hausen H. Partial characterization of viral DNA from human genital warts (Condylomata acuminata). Int. J. Cancer 25 (1980) 605-609
4. de Villiers E.M., Gissmann L., and zur Hausen H. Molecular cloning of viral DNA from human genital warts. J. Virol. 40 (1981) 932-935
5. Dürst M., Gissmann L., Ikenberg H., and zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc. Natl. Acad. Sci. U. S. A. 80 (1983) 3812-3815
6. Boshart M., Gissmann L., Ikenberg H., Kleinheinz A., Scheurlen W., and zur Hausen H. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J. 3 (1984) 1151-1157
7. Muñoz N., Bosch F.X., de Sanjosé S., Tafur L., Izarzugaza I., Gili M., et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int. J. Cancer 52 (1992) 743-749
8. IARC monographs on the evaluation of carcinogen risks to humans. Vol. 64. Human papillomaviruses. Views and expert opinion of an IARC Working Group Meeting; 1995 June 6-13; Lyon, France. WHO; 1995.
9. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 (1999) 12-19
10. Muñoz N., Castellsagué X., de González A.B., and Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 24 Suppl 3 (2006) S3/1-10
11. Koutsky L. The epidemiology behind the HPV vaccine discovery. Ann. Epidemiol. 19 (2009) 239-244
12. Parkin D.M., and Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine 24 Suppl 3 (2006) S3/11-25
13. D'Souza G., Kreimer A.R., Viscidi R., Pawlita M., Fakhry C., Koch W.M., et al. Case-control study of human papillomavirus and oropharyngeal cancer. N. Engl. J. Med. 356 (2007) 1944-1956
14. Moscicki A.B., Schiffman M., Kjaer S., and Villa L.L. Chapter 5: updating the natural history of HPV and anogenital cancer. Vaccine 24 Suppl 3 (2006) S3/42-51
15. de Sanjosé S., Diaz M., Castellsagué X., Clifford G., Bruni L., Muñoz N., et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect. Dis. 7 (2007) 453-459
16. Smith J.S., Lindsay L., Hoots B., Keys J., Franceschi S., Winer R., et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int. J. Cancer 121 (2007) 621-632
17. Castellsagué X., Díaz M., de Sanjosé S., Muñoz N., Herrero R., Franceschi S., et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J. Natl. Cancer Inst. 98 (2006) 303-315
18. Koutsky L. Epidemiology of genital human papillomavirus infection. Am. J. Med. 102 (1997) 3-8
19. Clifford G.M., Gallus S., Herrero R., Muñoz N., Snijders P.J., Vaccarella S., et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366 (2005) 991-998
20. Peto J., Gilham C., Deacon J., Taylor C., Evans C., Binns W., et al. Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br. J. Cancer 91 (2004) 942-953
21. Bosch F.X., Burchell A.N., Schiffman M., Giuliano A.R., de Sanjose S., Bruni L., et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 26 Suppl 10 (2008) K1-K16
22. Burchell A.N., Winer R.L., de Sanjosé S., and Franco E.L. Chapter 6: epidemiology and transmission dynamics of genital HPV infection. Vaccine 24 Suppl 3 (2006) S3/52-61
23. Manhart L.E., and Koutsky L.A. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex. Transm. Dis. 29 (2002) 725-735
24. Bleeker M.C., Hogewoning C.J., Voorhorst F.J., van den Brule A.J., Snijders P.J., Starink T.M., et al. Condom use promotes regression of human papillomavirus-associated penile lesions in male sexual partners of women with cervical intraepithelial neoplasia. Int. J. Cancer 107 (2003) 804-810
25. Winer R.L., Hughes J.P., Feng Q., O'Reilly S., Kiviat N.B., Holmes K.K., et al. Condom use and the risk of genital human papillomavirus infection in young women. N. Engl. J. Med. 354 (2006) 2645-2654
26. Castellsagué X., Bosch F.X., Muñoz N., Meijer C.J., Shah K.V., de Sanjose S., et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N. Engl. J. Med. 346 (2002) 1105-1112
27. Doorbar J. The papillomavirus life cycle. J. Clin. Virol. 32 Suppl 1 (2005) S7-S15
28. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2 (2002) 342-350
29. Cuschieri K.S., Cubie H.A., Whitley M.W., Gilkison G., Arends M.J., Graham C., et al. Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study. J. Clin. Pathol. 58 (2005) 946-950
30. Liaw K.L., Hildesheim A., Burk R.D., Gravitt P., Wacholder S., Manos M.M., et al. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J. Infect. Dis. 183 (2001) 8-15
31. Bosch F.X., Qiao Y.L., and Castellsagué X. CHAPTER 2 The epidemiology of human papillomavirus infection and its association with cervical cancer. Int. J. Gynaecol. Obstet. 94 Suppl 1 (2006) S8-S21
32. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin. Sci. (Lond) 110 (2006) 525-541
33. Stanley M.A. Human papillomavirus and cervical carcinogenesis. Best Pract. Res. Clin. Obstet. Gynaecol. 15 (2001) 663-676
34. Smith P.P., Bryant E.M., Kaur P., and McDougall J.K. Cytogenetic analysis of eight human papillomavirus immortalized human keratinocyte cell lines. Int. J. Cancer 44 (1989) 1124-1131
35. Herrero R., Hildesheim A., Bratti C., Sherman M.E., Hutchinson M., Morales J., et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J. Natl. Cancer Inst. 92 (2000) 464-474
36. McCredie M.R., Sharples K.J., Paul C., Baranyai J., Medley G., Jones R.W., et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 9 (2008) 425-434
37. Pett M., and Coleman N. Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis?. J. Pathol. 212 (2007) 356-367
38. Kalantari M., Calleja-Macias I.E., Tewari D., Hagmar B., Lie K., Barrera-Saldana H.A., et al. Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. J. Virol. 78 (2004) 12762-12772
39. Roberts J.N., Buck C.B., Thompson C.D., Kines R., Bernardo M., Choyke P.L., et al. Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat. Med. 13 (2007) 857-861
40. Day P.M., Thompson C.D., Buck C.B., Pang Y.Y., Lowy D.R., and Schiller J.T. Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition. J. Virol. 81 (2007) 8784-8792
41. Day PM, Gambhira R, Roden RB, Lowy DR, Schiller JT. Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1
42. Sankaranarayanan R., Nene B.M., Shastri S.S., Jayant K., Muwonge R., Budukh A.M., et al. HPV screening for cervical cancer in rural India. N. Engl. J. Med. 360 (2009) 1385-1394